Código QR (código de barras bidimensional)

Omalizumab may protect allergic patients against COVID-19: A systematic review

Omalizumab, which downregulates the immunoglobulin E (IgE) receptor site on plasmacytoid dendritic cells and thereby increases interferon-α (INF-α) production, may shorten the duration of viral infections by enhancing the antiviral immunity.A systematic review was conducted to investigate whether pr...

Fuld beskrivelse

Na minha lista:
Principais autores: Daniele Giovanni Ghiglioni, MD, ET Laura Cozzi, MD, Riccardo Castagnoli, MD, PhD, Gaia Bruschi, MD, Laura Maffeis, MD, Paola Giovanna Marchisio, MD, Gian Luigi Marseglia, MD, Amelia Licari, MD, PhD
Format: Artigo
Sprog:Inglês
Udgivet: Elsevier 2023-02-01
Serier:World Allergy Organization Journal
Fag:
COVID-19
Interferon
IFN-Alpha
Omalizumab
SARS-CoV-2
Online adgang:http://www.sciencedirect.com/science/article/pii/S1939455123000017
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker